Mpm Asset Management as of Sept. 30, 2015
Portfolio Holdings for Mpm Asset Management
Mpm Asset Management holds 16 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Radius Health | 62.2 | $404M | 5.8M | 69.31 | |
| Chiasma | 17.4 | $113M | 5.7M | 19.88 | |
| Portola Pharmaceuticals | 8.0 | $52M | 1.2M | 42.62 | |
| Epizyme | 3.4 | $22M | 1.7M | 12.86 | |
| Proteon Therapeutics | 2.1 | $14M | 983k | 13.91 | |
| Nevro (NVRO) | 1.5 | $9.8M | 212k | 46.39 | |
| Aratana Therapeutics | 1.4 | $9.5M | 1.1M | 8.46 | |
| Trivascular Technologies | 1.4 | $8.9M | 1.8M | 5.00 | |
| PharmAthene | 1.3 | $8.4M | 6.3M | 1.33 | |
| Conatus Pharmaceuticals | 0.8 | $5.3M | 1.2M | 4.45 | |
| Mast Therapeutics | 0.2 | $1.5M | 2.6M | 0.58 | |
| Verastem | 0.2 | $1.0M | 573k | 1.79 | |
| EnteroMedics | 0.0 | $289k | 1.1M | 0.26 | |
| Sangamo Biosciences (SGMO) | 0.0 | $127k | 23k | 5.65 | |
| Macrogenics (MGNX) | 0.0 | $68k | 3.2k | 21.46 | |
| Colucid Pharmaceuticals | 0.0 | $84k | 22k | 3.85 |
